OCUGEN, INC. Restricted Cash and Cash Equivalents, Noncurrent
OCUGEN, INC. (OCGN) had Restricted Cash and Cash Equivalents, Noncurrent of $137.00 thousand as of 2019-03-31, per its 10-Q filed 2019-05-15.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2019-08-09
- 2019-03-31: Restricted Cash and Cash Equivalents, Noncurrent $137.00K.
- 2018-12-31: Restricted Cash and Cash Equivalents, Noncurrent $137.00K.
- 2018-09-30: Restricted Cash and Cash Equivalents, Noncurrent $137.00K.
- 2018-06-30: Restricted Cash and Cash Equivalents, Noncurrent $137.00K.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent | Restricted Cash and Cash Equivalents, Noncurrent as first filed |
|---|---|---|
| 2019-03-31 | $137.00K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $137.00K 10-Q · filed 2019-08-09 | |
| 2018-09-30 | $137.00K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $137.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $137.00K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $137.00K 10-K · filed 2019-03-22 | |
| 2017-09-30 | $137.00K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $137.00K 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $137.00K 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $137.00K 10-K · filed 2018-03-15 | |
| 2016-09-30 | $137.00K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $137.00K 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $137.00K 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $137.00K 10-K · filed 2017-03-16 | |
| 2015-09-30 | $137.00K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $137.00K 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $604.00K 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $137.00K 10-K · filed 2016-03-10 | $604.00K 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |